Potential interactions between COVID-19 and CCC may be expected primarily due to the common immunological pathways shared by the diseases, as angiotensin-converting enzyme 2 (ACE2) is involved in heart function and the development of hypertension and diabetes mellitus, risk factors frequently observed in patients with CCC. The gene discussed is ACE2; the disease is diabetes mellitus.